News | April 23, 2026
AbbVie bets $1.4B on North Carolina pharma mega-campus
Once complete, the site will serve as AbbVie’s U.S. center of excellence for SVP manufacturing
Once complete, the site will serve as AbbVie’s U.S. center of excellence for SVP manufacturing
The investment will bring in cutting-edge downstream fermentation technology, strengthening the company’s contract manufacturing capabilities for drug substances
CLIRNET plans to expand globally and improve how medical knowledge is shared and used in practice
Together, the companies aim to deliver an integrated toolkit for biomarker discovery and clinical research
Bulling brings extensive experience across the biopharma and CDMO landscape, with leadership roles spanning both drug substance and drug product operations
Move comes amid rising regulatory pressures
If approved, the move would significantly broaden the use of KEYTRUDA and KEYTRUDA QLEX in combination with Padcev
Targets high-growth eye care expansion push
Inspection outcome reinforces company's compliance track record and strengthens its ability to serve regulated markets including the United States
By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership
Subscribe To Our Newsletter & Stay Updated
